GLS and breast carcinoma: The small molecule GLS inhibitors and extensively validated GLS shRNA constructs used in our studies allowed us to demonstrate that pharmacological inhibition of GLS or its knockdown has a profound effect on the growth of breast cancer cells in both in vitro and in vivo settings, which has not been reported thus far [10, 36].